Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis

Bruno Larrivée(Institut National de Santé Publique), Catarina Freitas(Inserm), Marc Trombe(Inserm), Xiang Lv(Inserm), Benjamin DeLafarge(Inserm), Yuan Li(Inserm), Karine Bouvrée(Inserm), Christiane Bréant(Inserm), R. Toro(Inserm), Nicolas Bréchot(Inserm), Stéphane Germain(Inserm), Françoise Bono(Sanofi (France)), Frédérique Dol(Sanofi (France)), Filip Claes(VIB-KU Leuven Center for Cancer Biology), Christian Fischer(VIB-KU Leuven Center for Cancer Biology), Monica Autiero(VIB-KU Leuven Center for Cancer Biology), Jean‐Léon Thomas(Inserm), Peter Carmeliet(VIB-KU Leuven Center for Cancer Biology), Marc Tessier‐Lavigne, Anne Eichmann(Inserm)
Genes & Development
October 1, 2007
Cited by 228Open Access
Full Text

Abstract

Netrins are secreted molecules with roles in axonal growth and angiogenesis. The Netrin receptor UNC5B is required during embryonic development for vascular patterning, suggesting that it may also contribute to postnatal and pathological angiogenesis. Here we show that unc5b is down-regulated in quiescent adult vasculature, but re-expressed during sprouting angiogenesis in matrigel and tumor implants. Stimulation of UNC5B-expressing neovessels with an agonist (Netrin-1) inhibits sprouting angiogenesis. Genetic loss of function of unc5b reduces Netrin-1-mediated angiogenesis inhibition. Expression of UNC5B full-length receptor also triggers endothelial cell repulsion in response to Netrin-1 in vitro, whereas a truncated UNC5B lacking the intracellular signaling domain fails to induce repulsion. These data show that UNC5B activation inhibits sprouting angiogenesis, thus identifying UNC5B as a potential anti-angiogenic target.


Related Papers